Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

MTIX

Micro Therapeutics (MTIX)

Micro Therapeutics (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MTIX
일자시간출처헤드라인심볼기업
2005/12/0901:01PR Newswire (US)ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
2005/11/1423:11PR Newswire (US)ev3 Inc. and Micro Therapeutics, Inc. Announce Merger AgreementNASDAQ:MTIXMicro Therapeutics (MM)
2005/10/2722:01PR Newswire (US)Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net SalesNASDAQ:MTIXMicro Therapeutics (MM)
2005/10/2722:00PR Newswire (US)ev3 Inc. Reports Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
2005/10/2123:00PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005NASDAQ:MTIXMicro Therapeutics (MM)
2005/10/1023:30PR Newswire (US)ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
2005/10/1022:30PR Newswire (US)Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc.NASDAQ:MTIXMicro Therapeutics (MM)
2005/10/0603:04PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
2005/08/0306:51PR Newswire (US)Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005NASDAQ:MTIXMicro Therapeutics (MM)
2005/08/0306:48PR Newswire (US)ev3 Inc. Reports Second Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
2005/07/2805:27PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005NASDAQ:MTIXMicro Therapeutics (MM)
2005/07/2207:27PR Newswire (US)ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
2005/07/2207:08PR Newswire (US)Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
2005/07/0707:30PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
2005/04/2906:14PR Newswire (US)Micro Therapeutics Reports 50% Net Sales Increase for 2005 First QuarterNASDAQ:MTIXMicro Therapeutics (MM)
2005/04/2602:28PR Newswire (US)Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005NASDAQ:MTIXMicro Therapeutics (MM)
2005/03/2206:57PR Newswire (US)ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
2005/02/1105:23PR Newswire (US)Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
2005/02/1021:45PR Newswire (US)Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on FebruaryNASDAQ:MTIXMicro Therapeutics (MM)
2005/02/0808:40PR Newswire (US)Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005NASDAQ:MTIXMicro Therapeutics (MM)
2005/02/0121:00PR Newswire (US)Micro Therapeutics Receives $3.7 Million PaymentNASDAQ:MTIXMicro Therapeutics (MM)
2004/12/3002:13PR Newswire (US)Micro Therapeutics Consolidates Manufacturing CapabilitiesNASDAQ:MTIXMicro Therapeutics (MM)
2004/12/0705:04PR Newswire (US)ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
2004/11/1023:00PR Newswire (US)ev3 International Files Lawsuit Against Distributors in Hong Kong and PhoenixNASDAQ:MTIXMicro Therapeutics (MM)
2004/11/0421:00PR Newswire (US)Micro Therapeutics Reports 2004 Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
2004/11/0205:24PR Newswire (US)Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4NASDAQ:MTIXMicro Therapeutics (MM)
2004/10/2200:47PR Newswire (US)FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long StentsNASDAQ:MTIXMicro Therapeutics (MM)
2004/09/2122:01PR Newswire (US)ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft UseNASDAQ:MTIXMicro Therapeutics (MM)
2004/08/2701:33PR Newswire (US)ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting ProceduresNASDAQ:MTIXMicro Therapeutics (MM)
2004/08/1902:51PR Newswire (US)Micro Therapeutics Completes Issuance of Common Stock for Exchangeable NotesNASDAQ:MTIXMicro Therapeutics (MM)
 검색 관련기사 보기:NASDAQ:MTIX

최근 히스토리

Delayed Upgrade Clock